Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
7.31B | 7.10B | 6.62B | 6.29B | 5.37B | 5.18B | Gross Profit |
1.90B | 3.42B | 3.17B | 2.98B | 2.52B | 2.55B | EBIT |
1.79B | 1.69B | 1.26B | 1.42B | 1.18B | 1.19B | EBITDA |
2.47B | 2.40B | 1.98B | 2.25B | 1.77B | 1.60B | Net Income Common Stockholders |
1.18B | 1.20B | 770.00M | 1.17B | 803.00M | 675.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
156.00M | 315.00M | 209.00M | 186.00M | 200.00M | 294.00M | Total Assets |
7.41B | 11.71B | 10.86B | 10.89B | 10.07B | 8.90B | Total Debt |
3.12B | 4.27B | 4.10B | 4.10B | 4.34B | 4.41B | Net Debt |
2.96B | 3.95B | 3.90B | 3.92B | 4.16B | 4.14B | Total Liabilities |
4.97B | 7.04B | 6.90B | 6.89B | 6.95B | 6.62B | Stockholders Equity |
2.42B | 4.63B | 3.93B | 3.97B | 3.08B | 2.27B |
Cash Flow | Free Cash Flow | ||||
1.77B | 1.11B | 1.09B | 1.29B | 1.07B | 769.00M | Operating Cash Flow |
1.80B | 1.75B | 1.72B | 1.80B | 1.49B | 1.26B | Investing Cash Flow |
-1.69B | -1.10B | -948.00M | -1.12B | -827.00M | -1.18B | Financing Cash Flow |
-56.00M | -551.00M | -722.00M | -687.00M | -747.00M | 61.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $47.09B | 40.59 | 24.24% | 1.08% | 7.93% | 14.86% | |
74 Outperform | $44.85B | 46.95 | 475.86% | 0.51% | 7.20% | 27.36% | |
73 Outperform | $33.06B | 54.36 | 12.83% | 0.63% | 7.12% | 9.05% | |
73 Outperform | $16.79B | 46.09 | 8.68% | 0.51% | 8.85% | ― | |
66 Neutral | $4.48B | 12.26 | 5.32% | 248.53% | 4.10% | -12.36% |